title: [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].
abstract: Alpha-fetoprotein (AFP) is an alpha1-glycoprotein (M.W. about 65000) appearing in the fetal serum of most mammals including man during the early stages of pregnancy; 4 weeks after birth it disappears altogether or exists at very low concentrations as in the normal adult. AFP is formed in the yolk sac, the fetal liver and the gastro-intestinal tract. One of its physiological functions in fetal life is supposed to be the protection of the fetus from maternal oestrogens (oestrophilic property). The clinical significance of AFP is based on the regular and increasing production in primary liver cell carcinoma, less frequently in teratogenetic tumors where it serves as a control of therapy and course of the disease. Less frequent, minor and temporary increases in the AFP serum level occur in several primary tumors with secondary liver involvement, and in inflammatory gastro-intestinal diseases, e.g. of the liver (hepatitis, cirrhosis). AFP has an increasing importance in gynecology (gestational age, fetal distress syndrom, malformations, hydatidiform mole/chorion carcinoma). The physico-chemical properties of AFP are widely known. Both fetal and tumor AFP appear to be immunologically and biochemically identical, as are that of tissue and biological fluids. The differences observed (variants, microheterogeneity) depend mainly on the different content of sialic acid. An antigenetic relationship exists, between the AFP of most species. The immunodiffusion (Ouchterlony) is the most frequently used but relatively insensitive test (1-5 mug/ml) in finding AFP, whereas the radioimmunoassay is the most sensitive one (up to 0,25 ng/ml) and permits the determination of normal serum levels in adults (below 20 ng/ml). The serum concentration in healthy pregnant women lies up to 500 ng/ml, in patients with hepatitis, liver cirrhosis and other liver diseases mostly under 3 mug/ml, whereas in those with primary liver cell carcinoma levels up to and above 600 mg-percent have been found.
mesh_terms: D000367:Age Factors; D000653:Amniotic Fluid / Q000032:analysis; D000818:Animals; D001208:Asia; D001769:Blood; D002272:Carcinoembryonic Antigen; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000276:immunology; D002645:Chickens; D005060:Europe; D005260:Female; D005326:Fetal Proteins / Q000096:biosynthesis / Q000276:immunology / Q000502:physiology; D005865:Gestational Age; D006023:Glycoproteins; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D007231:Infant, Newborn; D008107:Liver Diseases / Q000097:blood; D008113:Liver Neoplasms / Q000276:immunology; D008297:Male; D009369:Neoplasms / Q000276:immunology; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013724:Teratoma / Q000097:blood; D014470:Umbilical Cord; D014481:United States
chemical_list: D002272:Carcinoembryonic Antigen; D005326:Fetal Proteins; D006023:Glycoproteins; D006511:Hepatitis B Antigens
vernacular_title: Carcinofetale Antigene. I. Alpha-Fetoprotein